Holiday Spirit and Animal Spirits
Motley Fool Money
00:00
Weight Watchers' Strategic Shift
This chapter explores Weight Watchers' new strategy of integrating weight loss drugs like Ozempic and Wegovy into their business model. The discussion highlights the acquisition of Sequence, a telehealth company, which positions Weight Watchers to offer these medications through a subscription service. Additionally, the chapter examines the broader implications for the weight loss industry and investor perspectives on adapting to emerging trends in personal finance.
Transcript
Play full episode
